Duality announced the appointment of Dr. Yver as Chairman of SAB

/PRNewswire/ -- Duality Biotherapeutics, Inc. ("Duality" or "the Company") today announced the appointment of Dr. Antoine Yver as Chairman of SAB. Dr. Antoine...

Related Keywords

China ,Saclay ,France General ,France ,United States ,Shanghai ,Paris ,Suzhou ,Jiangsu ,John Zhu ,Rhone Poulenc Rorer ,Daiichi Sankyo ,Antoine Yver ,Duality Biotherapeutics Inc ,Development At Centessa Pharmaceuticals Ltd ,Schering ,Astrazeneca ,Aventis Group ,University Of Paris ,Johnson ,Antibody Drug Conjugates ,Centessa Pharmaceuticals ,Executive Vice President ,Global Head ,Cancer Enterprise ,Senior Vice President ,Duality Immune Toxin Antibody Conjugate ,Translate Novel Modality ,First In Class Antibody Drug Conjugate ,Antibody Drug Conjugate ,Duality Immune Modulating Antibody Conjugate ,Dualitybio ,